
BioStem Technologies, Inc.
BSEMHealthcare|Biotechnology|US
$1.13
+0.09 (+8.65%)
Tangible Book / Share
$0.27
Cash / Share
$0.40
Next Earnings Report
Nov 12, 2026
EPS est. -$0.43 · Revenue est. $7.2M
Financing Filings (last 12 months)
8
Shelf registrations / offering prospectuses — latest Oct 13, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
BioStem Technologies to Host Third Quarter 2026 Financial Results Conference Call on November 12, 2026
Oct 29, 2026 · GlobeNewsWire
BioStem Technologies' CEO and COO Invest $1 Million in Cash Through Exercise of Stock Options
Oct 8, 2026 · MCAP MediaWire
BioStem Technologies' CEO and COO Invest $1 Million in Cash Through Exercise of Stock Options
Oct 8, 2026 · GlobeNewsWire
BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio
Oct 1, 2026 · MCAP MediaWire
BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio
Oct 1, 2026 · GlobeNewsWire
BioStem Technologies Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Sep 30, 2026 · MCAP MediaWire
BioStem Technologies Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Sep 30, 2026 · GlobeNewsWire
Terminal1, the operating system built for public companies, announced today that BioStem Technologies, Inc. (NASDAQ: BSEM) has joined the Terminal1 platform
Sep 21, 2026 · GlobeNewsWire
BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility
Sep 18, 2026 · MCAP MediaWire
BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility
Sep 18, 2026 · GlobeNewsWire
SEC Filings (29)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 5, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Oct 13, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Oct 9, 2026 | EFFECT | DocumentIndex | |
| Oct 9, 2026 | D | DocumentIndex | |
| Oct 6, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Oct 2, 2026 | S-1 | IPO / offering registration | DocumentIndex |
| Sep 30, 2026 | 8-K | Material event | DocumentIndex |
| Sep 29, 2026 | EFFECT | DocumentIndex | |
| Sep 29, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Sep 21, 2026 | D | DocumentIndex | |
| Sep 18, 2026 | S-1 | IPO / offering registration | DocumentIndex |
| Sep 18, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Aug 13, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Aug 12, 2026 | 8-K | Material event | DocumentIndex |
| Aug 12, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 11, 2026 | EFFECT | DocumentIndex | |
| Aug 7, 2026 | S-1/A | IPO / offering registration | DocumentIndex |
| Aug 7, 2026 | 8-K | Material event | DocumentIndex |
| Aug 7, 2026 | SEC STAFF ACTION | DocumentIndex | |
| Aug 6, 2026 | CERT | DocumentIndex | |
| Aug 4, 2026 | 10-12B/A | DocumentIndex | |
| Jul 29, 2026 | S-1 | IPO / offering registration | DocumentIndex |
| Jul 24, 2026 | 10-12B/A | DocumentIndex | |
| Jul 10, 2026 | 10-12G | DocumentIndex | |
| Jun 3, 2026 | D | DocumentIndex | |
| Oct 28, 2025 | RW | DocumentIndex | |
| Jan 23, 2025 | 10-12B/A | DocumentIndex | |
| Nov 27, 2024 | 10-12B/A | DocumentIndex |